Vendor, Boulder, CO
Vitrivax, Inc.
UEI VFTQREMA1CZ4, CAGE 8LMB7
1 award and $11,721,060 obligated between January 4, 2024 and May 14, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $11,721,060 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HDTRA123C0009Definitive Contract, January 4, 2024, Full and Open Competition, 1 offers | Defense Threat Reduction AgencyDefense Threat Reduction Agency | Optimization and Production of Single-Shot Vaccines for Melioidosis and GlandersNAICS 541715, PSC AC33 | $11,721,060 |
- Places of performance
- Colorado
- Product and service codes
- AC33 National Defense R&D Services; Defense-Related Activities; Experimental Development
- Transactions
- 11 across 1 awards